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Abstract Transhydrogenase, in animal mitochondria and bac-
teria, couples hydride transfer between NADH and NADP+ to
proton translocation across a membrane. Within the protein, the
redox reaction occurs at some distance from the proton trans-
location pathway and coupling is achieved through conforma-
tional changes. In an ‘open’ conformation of transhydrogenase,
in which substrate nucleotides bind and product nucleotides dis-
sociate, the dihydronicotinamide and nicotinamide rings are held
apart to block hydride transfer; in an ‘occluded’ conformation,
they are moved into apposition to permit the redox chemistry. In
the two monomers of transhydrogenase, there is a reciprocating,
out-of-phase alternation of these conformations during turnover.
' 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Transhydrogenase operates at an important three-way in-
terface between the two major, soluble redox cofactors in the
cell ^ NAD(H) and NADP(H) ^ and the proton electrochem-
ical gradient (vp). Under most physiological conditions in
animal mitochondria and bacteria, the enzyme is a consumer
of vp :
NADH þNADPþ þHþoutINADþ þNADPHþHþin ð1Þ
The energy of the gradient can drive the [NADPH][NADþ]/
[NADPþ][NADH] ratio to values s 400. The resulting
NADPH is used for biosynthesis and for reduction of gluta-
thione (needed, for example, to limit damage caused by free
radicals generated in the respiratory chain) [1]. The physio-
logical role of transhydrogenase has a more subtle aspect in
mitochondria from some animal tissues (e.g. heart and
muscle) where, in principle, the NADP-linked isocitrate dehy-
drogenase has a greater capacity to produce NADPH than
transhydrogenase. Here, it is thought that transhydrogenase
and the two isocitrate dehydrogenases (the NAD- and NADP-
linked enzymes) together catalyse a ‘mini-cycle’ between iso-
citrate and K-ketoglutarate that ¢ne-tunes the regulation of
the Krebs tricarboxylic acid pathway. An increased rate of
consumption of vp is the metabolic price to pay for the im-
proved control [2].
Although transhydrogenase catalyses a redox reaction, its
energy-coupling processes probably have more in common
with those of F1Fo-ATP synthase than with those of the res-
piratory chain complexes: (a) in transhydrogenase and the
F1Fo-ATP synthase, nucleotide-binding changes at the cata-
lytic site are central to the mechanism, and (b) in both pro-
teins the nucleotide-binding site is located some distance from
the proton translocation pathway and linkage is achieved by
conformational change. In this article, information on the
coupling mechanism that emerges from recent kinetic and
thermodynamic experiments and from considerations of re-
cent X-ray structures of transhydrogenase components will
be reviewed. The main theme is that coupling depends cru-
cially on movements of the nicotinamide rings of the nucleo-
tides either to block or to permit hydride transfer.
2. Transhydrogenase basics (for earlier reviews, see [3^5])
1. Transhydrogenase is the only ion translocator that we are
aware of in which the standard free energies of the prod-
ucts of the scalar chemical reaction are similar to those of
the reactants.
2. One proton is translocated per hydride ion equivalent
transferred from NADH to NADPþ.
3. The transhydrogenase reaction is stereospeci¢c for the C4A
(pro-R) hydrogen of the dihydronicotinamide ring of
NADH and the C4B (si) face of the nicotinamide ring of
NADPþ.
4. There is no intrinsic hydrogen exchange between the re-
duced nucleotide and water protons during enzyme turn-
over.
3. Transhydrogenase architecture
The global structure of transhydrogenase is very similar in a
wide variety of organisms. The dI component, which binds
NADþ/NADH, and the dIII component, which binds
NADPþ/NADPH, protrude from the membrane ^ on the ma-
trix side in mitochondria and on the cytoplasmic side in bac-
teria (Fig. 1). The dII component spans the membrane. The
intact enzyme is essentially a dimer of two dI+dII+dIII
‘monomers’ (designated A and B), although there is variability
in the arrangement of the polypeptides amongst species.
The dI component has two domains, dI.1 and dI.2 [6^8].
Both comprise parallel twisted L-sheets £anked by helices and
have the form and connectivity of the Rossmann fold. They
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are separated by a deep cleft and linked by two long helices
(K6 and K11). The NADþ/NADH-binding site is located with-
in the cleft. A GXGXXG ‘¢ngerprint’, characteristic of a class
of proteins that bind nicotinamide nucleotides [9], is located in
the loop at the N-terminus of the ‘pyrophosphate-binding’
helix in dI.2. The speci¢city of NADþ/NADH over NADPþ/
NADPH probably derives from the H-bond interaction be-
tween Asp202 (Rhodospirillum rubrum numbering1) and the
2P-OH of the adenosine ribose. The dI polypeptides that
form the physiological dimer are related by a two-fold axis
of pseudo-symmetry that runs through a central ‘core’ formed
by the dI.2 domains. A L-hairpin structure of some 13 resi-
dues extends from each dI.2 domain across the back of the
symmetry-related subunit and contributes to the wall of its
nucleotide-binding site. The fold of dI is similar to that of
alanine dehydrogenase, a water-soluble bacterial enzyme,
which catalyses the reductive amination of pyruvate to ala-
nine. This raises the possibility that an ancestor of alanine
dehydrogenase was recruited by a membrane protein in the
molecular evolution of transhydrogenase.
Transhydrogenase dIII has a single domain which also has
the form and connectivity of the Rossmann fold [10^12]. A
very unusual feature is that the bound NADPþ has a £ipped
orientation relative to that commonly found with nucleotides
in the Rossmann fold. Thus, the adenosine moiety is located
over the second LKLKL motif of the fold and the nicotinamide
mononucleotide over the ¢rst. A GXGXXA sequence matches
the ¢ngerprint for NADP-dependent enzymes (compare
above) but, remarkably, it appears to have a di¡erent func-
tional relationship with the bound nucleotide to that in other
proteins. Speci¢city for NADPþ/NADPH over NADþ/NADH
results from a complex nest of H-bonds between Lys164,
Arg165 and Ser166 (R. rubrum isolated dIII numbering) and
the 2P-phosphate group on the adenosine ribose. Transhydro-
genase dIII has a similar fold to that of the FAD-binding
domain of the soluble protein, pyruvate oxidase, and here
too the adenosine moiety of the FAD is bound to the second
LKLKL motif.
A stable dI2dIII1 complex forms spontaneously in mixtures
of separately prepared, recombinant dI and dIII [12,13]. The
crystal structure of the complex shows that the single dIII
polypeptide is associated with the cleft of just one of the
two dI polypeptides (designated the B polypeptide ^ see Fig.
1). The dIII polypeptide makes extensive contacts with the
dI.2 core of the dI dimer. Though they are few, the contacts
between dIII and dI.1(B) involve highly conserved regions of
the protein and are probably important in the transmission of
conformational changes during the coupling of proton trans-
location to the redox reaction (see later). The single hydride
transfer site in the complex is at the dI/dIII interface.
There is no high-resolution structure of the membrane-
spanning dII component but hydropathy analysis of amino
acid sequences [3^5] and biochemical experiments, particularly
after engineering unique Cys residues into the protein [14,15],
have led to the conclusion that the single-subunit, mammalian
transhydrogenases have 14 transmembrane (TM) helices (28
per dimer), the two-subunit enzymes from bacteria (e.g. Es-
cherichia coli) have 13 (26 per dimer) and the three-subunit
enzymes from bacteria (e.g. R. rubrum) have 12 (24 per
dimer). Helices 3, 4, 9, 10, 13 and 14 (mammalian numbering)
are the most conserved. There is little experimental informa-
tion to indicate how the helices are clustered, though there are
predictions based on the locations of conserved amino acid
residues (see [15,16]). The loops between TM helices are
thought to be quite short (6 14 residues on the cytoplasmic
side of the membrane in bacteria, and 6 25 residues on the
periplasmic side). The cytoplasmic loops, some of which must
interact with dIII, are more conserved.
The overall arrangement of components in the intact en-
zyme can be deduced from the crystal structure of the dI2dIII1
complex (Fig. 1) [7]. A second dIII (probably in a di¡erent
conformational state to that observed in dI2dIII1 ^ see below)
must be located at or close to the vacant cleft of dI(A). The
two dII components are probably associated mainly with the
two dIII components. In the three-subunit transhydrogenases,
it is likely that there is no contact between dI and dII ^ thus
dI can be easily displaced from (and then reconstituted to re-
form) the intact enzyme [17]. In the one- and two-subunit
enzymes, there is a direct connection between dI and dII
but only through a single strand of unconserved polypeptide
chain.
4. Direct hydride transfer in the enzyme catalytic site
dI2dIII1 complexes catalyse a rapid single-turnover burst of
transhydrogenation [18^21]. In the absence of dII, further
turnover is limited by the extremely slow rate of release of
the product nucleotide (NADPþ or NADPH, depending on
direction) from dIII. Acetylpyridine adenine dinucleotide
(AcPdADþ) and AcPdADH are good analogues of NADþ
and NADH in transhydrogenation but the optical absorbance
Fig. 1. The domain structure and some important secondary-struc-
ture features in transhydrogenase. The upper part of the ¢gure is a
surface representation of the crystal structure of the dI2dIII1 com-
plex of R. rubrum transhydrogenase [7] showing positive and nega-
tive Coulombic ¢elds in blue and red, calculated by the program
GRASP [47]. Bound NADPþ, partly obscured by loop E, can be
seen (in stick format) in the dIII component but dI(B) lacks
NAD(H) in the crystal structure. Features referred to in the text
are: a, the cleft between domains dI.1 and dI.2; b, the mobile loop
of dI (truncated in this structure due to weak electron density);
c, the TAGP loop of dI; d, helix D/loop D of dIII; e, the loop E
‘lid’ of dIII. The lower part of the ¢gure shows the probable posi-
tion of the second dIII component and the two dII components of
the intact enzyme in the membrane.
1 Unless otherwise stated, the amino acid numbering system is for
Rhodospirillum rubrum transhydrogenase. For the dIII component of
the enzyme, the sequence number of the isolated recombinant protein
is given.
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of AcPdADH is shifted relative to that of NADH and
NADPH. Thus it was shown, for the reaction between
AcPdADþ and NADPH on dI2dIII1 complexes, that the ki-
netics of AcPdADþ reduction and of NADPH oxidation are
identical [18]. Similarly, with AcPdADH and NADPþ, the
AcPdADH oxidation kinetics precisely match those of
NADPþ reduction [20]. This proves that hydride transfer is
direct; there are no redox intermediates in transhydrogenase.
During the physiological reaction in the intact enzyme, the
pro-R C4H of the dihydronicotinamide ring of NADH must
come into apposition with the si face of C4 of the NADPþ
nicotinamide at the redox step.
This simple conclusion must be considered alongside the
fact that dihydronicotinamide and nicotinamide rings are
highly reactive. Even in aqueous solution in the absence of
enzymes, there can be a considerable rate of reaction between
reduced and oxidised nicotinamide nucleotides and their ana-
logues: second-order rate constants are in the order 1032^
1033 M31 s31 [22,23]. At the low concentration of nicotin-
amide nucleotides in the living cell, and in most experiments
with transhydrogenase, the non-enzymic rate is insigni¢cant.
However, there is an important consequence of these substan-
tial reactivities for the coupling mechanism of transhydroge-
nase: the dihydro- and nicotinamide rings of the NADH and
the NADPþ, respectively, must be kept apart when the nu-
cleotides bind to the enzyme. If NADH and NADPþ were
permitted to bind with their nicotinamide C4 atoms in appo-
sition, a disastrous redox reaction would ensue uncoupled
from proton translocation and driven by the solution vG of
the nucleotides.
5. The binding-change mechanism
In the framework of the ‘binding-change’ model of trans-
hydrogenase [3,24], the requirement to move the dihydro- and
the nicotinamide rings towards and away from one another
becomes central in the mechanism of coupling. Two confor-
mational states of each monomer in the intact enzyme are
recognised (see Fig. 2, and note that the transhydrogenase is
shown with its monomers in alternating conformations, as will
be discussed later). In the ‘open’ state, bound nucleotides can
rapidly exchange with those in the solvent but the nicotin-
amide rings of the bound nucleotides are held apart to prevent
redox reaction. It is from the open state that product nucleo-
tides can dissociate and fresh substrates can bind. In the ‘oc-
cluded’ state, bound nucleotides cannot exchange with those
in the solvent and their nicotinamide rings are held together to
favour hydride transfer. The open and occluded states are
inter-converted by protonation and deprotonation reactions
associated with translocation of protons through dII. Direc-
tionality is imposed by changing access of the translocation
‘device’ in dII (about which very little is known ^ see below)
to protons from either one side of the membrane or the other,
depending on the nucleotide occupancy of dIII.
At neutral pH, dI2dIII1 complexes are locked in a confor-
mation resembling the occluded state [25]. They catalyse very
fast hydride transfer at their single dI/dIII interface but release
NADPþ and NADPH from dIII only very slowly. The crystal
structures indicate that the extended ‘loop E’, arching over
and enclosing the pyrophosphate group of the bound
NADPþ, is at least partly responsible for the occlusion of
the nucleotide from the solvent (Fig. 1) [11,12]. The tyrosyl
ring of the highly conserved Tyr171 in a GYA sequence at the
apex of the loop interacts with the NADPþ nicotinamide ring
and with the invariant Arg90. In turn, this arginine is in van
der Waals contact with the nicotinamide ring and its guani-
dinium group makes an H-bond with the nucleotide pyro-
phosphate. After hydride transfer in the intact enzyme, there
must be a loosening of these interactions during conversion to
the open state to allow retraction of loop E and release of the
NADPH product into the solvent. In isolated dIII and in
dI2dIII1 complexes, loop E is retracted when the proteins
are exposed to low pH [26].
The so-called mobile loop of dI, ¢rst identi¢ed and charac-
terised by nuclear magnetic resonance (NMR) spectroscopy
[27,28], has some similarities with loop E of dIII. It too has
a highly conserved tyrosine (Tyr235) in a GYA sequence, and
the tyrosyl ring of this residue can make van der Waals con-
tact with an invariant arginine (Arg127). As with its dIII
counterpart, this arginine is in contact with the nicotinamide
ring (but of NADþ) and its guanidinium group H-bonds to
the nucleotide pyrophosphate. NMR experiments show that
the loop closes down during NAD(H) binding to dI. In X-ray
di¡raction data, the electron density for the loop is well-de-
¢ned in some subunits of isolated dI (where it interacts with
the strongly conserved TAGP loop ^ see Fig. 1), but not at
the hydride transfer site of dI2dIII1 complexes. Like loop E in
dIII, it might have a function in the occlusion of nucleotide
from the solvent during hydride transfer.
The crystal structure of isolated dI with bound NADþ pro-
vides a clear indication that the nicotinamide ring of the
bound nucleotides in transhydrogenase can move across sig-
ni¢cant distances, as proposed in the binding-change mecha-
nism [6]. There are four polypeptides in the asymmetric unit
of the crystals. In two of these, the electron density for the
NADþ nicotinamide is well-de¢ned and reveals distinctively
di¡erent NADþ conformations (Fig. 3). In one polypeptide,
the nicotinamide is syn relative to the ribose and is located at
the back of the cleft between domains dI.1 and dI.2. In the
other, rigid-body movement of dI.1 relative to d1.2 has caused
the nicotinamide group to rotate into the anti conformer and
to be expelled towards the rim of the cleft. The possible sig-
Fig. 2. The binding-change mechanism of transhydrogenase. In the
‘open’ state, bound nucleotides can exchange with those in the sol-
vent, and hydride transfer between NADH and NADPþ is blocked
^ the dihydronicotinamide and nicotinamide rings (shaded) are kept
apart. In the ‘occluded’ state, bound nucleotides cannot exchange
with those in the solvent and hydride transfer is allowed ^ the two
rings are brought together. The conformational states of the two
monomers of transhydrogenase (one monomer in red and the other
in blue) alternate during turnover.
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ni¢cance of these conformational changes in promoting or
blocking the redox reaction was revealed by the subsequent
structural analysis of dI2dIII1 complexes [7]. The structure of
the complexes was solved for protein having bound NADþ
and NADPþ (to ensure that there was no redox reaction
during crystallisation). The dIII site is fully occupied by
NADPþ but only the dI(A) polypeptide (whose cleft is not
associated with dIII) has strong electron density for bound
NADþ. Therefore to visualise the hydride transfer reaction,
an NADH molecule was modelled into dI(B) in the same
conformation as, and in the equivalent binding site to, the
NADþ in dI(A). In this (‘distal’) state, C4 of the NADH
dihydronicotinamide is 6.5 AS from C4 of the NADPþ nico-
tinamide ^ too far for hydride transfer (see Fig. 4). However,
by applying small rotations equivalent to those described
above in isolated dI, the two rings can be moved into appo-
sition, thereby bringing the two C4 atoms into van der Waals
contact (the ‘proximal’ state).
This organisation will thus set the trajectory for the forma-
tion of the transition state for hydride transfer and will lead to
the correct stereochemistry. It is proposed that the movements
between the distal (redox-inactive) and proximal (redox-ac-
tive) states in the model re£ect real events in the intact enzyme
during inter-conversion of the open and occluded conforma-
tions, as illustrated by the Fig. 2 cartoon. There is a sugges-
tion of a corresponding conformational shift in the NADPþ
molecule ^ a pocket in dIII (occupied by glycerol in the X-ray
structure) is appropriately positioned to house NADPþ-nico-
tinamide rotated away from the NADH in the open state [11].
The relative motions of dI.1 and dI.2 required to move the
NADH dihydronicotinamide, the opening and closing of loop
E and the movements of the NADPþ nicotinamide are all
thought to result from conformational changes in the helix
D region of dIII which are driven by proton translocation
though dII (see below).
The invariant dI residue, Gln132, appears to have an im-
portant role in maintaining the proximal state for hydride
transfer (Fig. 4). In the dI2dI1 crystal structure, the side-chain
amide of this residue extends across the interface with dIII
and makes H-bond contact with the 2P-OH group of the
NADPþ ribose. In the modelled proximal state, Gln132 can
make an additional H-bond with the 3-carboxamide group of
the NAD nicotinamide, which led to the suggestion that the
residue is a ‘molecular tether’ to hold the two nucleotides
together in the pre-transition state for hydride transfer [29].
When Gln132 was replaced by Asn, the NADH-binding af-
¢nity of the isolated dI was unchanged but hydride transfer in
complexes formed from the mutant protein and wild-type dIII
was very strongly inhibited. X-ray crystallography shows that
these complexes fold correctly but the shorter side chain of
residue 132 results in a failure of the tether. In the structure of
dI.NADH [8] (but not in dI.NADþ [6]), the invariant Arg204
makes H-bond contact with hydroxyl groups in both the nic-
otinamide ribose and the adenosine ribose ^ this bridge might
also be important to constrain the structure of the nucleotide
during the shift between the distal and proximal positions at
the hydride transfer site.
6. Changes in nucleotide binding energy
The on-enzyme equilibrium constant of the hydride transfer
step of transhydrogenase is s 36-fold greater than that in free
solution [20,21]. This must be the result of a stabilisation of
NADPH (relative to NADPþ) and/or of NADþ (relative to
NADH) in the occluded state, and its signi¢cance requires
comment. The catalytic site of transhydrogenase operates in
a solution environment (the bacterial cytoplasm and the mi-
Fig. 4. The hydride transfer site of transhydrogenase. A MOL-
SCRIPT [48] cartoon taken from the crystal structure of the
dI2dIII1 complex of R. rubrum transhydrogenase [7]. A segment of
the dI(B) polypeptide is shown in green and an adjacent segment of
the dIII polypeptide in red. The bound NADPþ molecule and some
of the invariant amino acid residues in the active site are in their
conventional atom colours. An NADH molecule (dark grey) is
modelled into dI(B) in the same conformation as, and at the equiva-
lent site to, the NADþ in dI(A) ^ this is denoted the ‘distal’ posi-
tion (see text). The nicotinamide mononucleotide moiety of the
NADH was then rotated (compare Fig. 3) into the ‘proximal’ posi-
tion as shown by the nucleotide molecule in conventional atom col-
ours: in this conformation the C4 atoms of the NADH and
NADPþ (both coloured light blue) are within hydride transfer dis-
tance (light blue dots). The tethering function of Gln132 in stabilis-
ing the proximal arrangement is illustrated: hydrogen bonds be-
tween this residue and both the bound NADPþ and the modelled
NADH are shown as orange dots.
Fig. 3. Di¡erent NADþ conformations in the subunits of isolated
dI. The A (pale blue) and D (dark blue) polypeptides from the
asymmetric unit of isolated dI of R. rubrum transhydrogenase were
superposed using amino acid residues in the L-sheets of the dI.2 do-
mains and displayed as CK traces using MOLSCRIPT [48]. Note
the resulting misalignment of the dI.1 domains of polypeptides A
and D, due to hinge movement in helices K6 and K11 (which run
across the clefts), and the pronounced movements in the nicotin-
amide mononucleotide moieties of the bound NADþ. The nucleo-
tide of polypeptide A is shown in red, and that of D is shown in
violet. Note that the polypeptide labelling of isolated dI does not
correspond to that in the dIdIII complex (Figs. 1 and 4).
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tochondrial matrix) where NADþ/NADH is somewhat oxi-
dised and NADPþ/NADPH is (usually) very reduced. Al-
though Kd values are unavailable, the enzyme in its open
state is therefore expected to bind NADH and NADPþ with
high a⁄nity relative to NADþ and NADPH (thus promoting
substrate binding and product release). Were these relative
a⁄nities to remain unchanged during conversion to the oc-
cluded state, then the Keq for hydride transfer would be un-
favourable and the enzyme would be trapped in a ‘thermody-
namic pit’ ^ in principle, the transhydrogenase would still
work and still be fully coupled to proton translocation but
it would operate at a low rate (see [30]). A change in binding
energies of the two nucleotides during inter-conversion of the
open and occluded states avoids the problem. Note that nu-
cleotide occlusion, which, as explained above, is essential to
prevent the redox reaction becoming uncoupled from proton
translocation, is also necessary for this change in binding af-
¢nities; for example to allow destabilisation of the newly
bound substrates, NADPþ and NADH, without their disso-
ciating from the protein before hydride transfer.
7. The hydride transfer reaction
Quantum-mechanical (AM1) calculations show that the en-
ergy cost to pucker the planar 1,4-dihydronicotinamide ring
into a quasi-boat form (KN =KC = 10‡) is only 1.7 kcal/mol.
This is small relative to the decrease in energy of the transition
state for hydride transfer of dog¢sh lactate dehydrogenase
that can be achieved by the deformation [31]. The ring pucker
puts the pro-R atom at C4 into a pseudoaxial position and
this is thought to increase the driving force for hydride trans-
fer by allowing greater orbital overlap during the reaction.
That this e¡ect might be kinetically signi¢cant was shown
by molecular dynamics calculations on several dehydrogen-
ases ^ there was a preference for the C4H atom of the dihy-
dronicotinamide ring to be transferred to pucker towards the
substrate-binding pocket. In transhydrogenase, the rate of hy-
dride transfer between NADH and NADPþ is extremely rapid
(kappW21 000 s31 in dI2dIII1 complexes [21]) ^ signi¢cantly
more rapid than substrate oxidation/reduction by NAD(P)(H)
in the soluble dehydrogenases. Although we expect at least
modest rates of hydride transfer in transhydrogenase simply
as a result of binding and orientation of the nucleotides (see
above), activation of the nicotinamide rings, for example by
ring puckering, is not ruled out.
The conserved amino acid residues in the hydride transfer
site were identi¢ed in the crystal structures [6^8,10^12]. Of
particular note is the almost invariant run of 10 residues
(Ile84^Gly93) in the binding loop for the NADPþ nicotin-
amide in dIII, the invariant polar/charged residues, Arg127,
Gln132, Asp135 and Ser138 (in the ‘RQD’ loop) of dI, which
can all interact with the NAD(H) nicotinamide (see Fig. 4),
and the conserved tyrosines (Tyr235 in dI, and Tyr54 and
Tyr171 in dIII). These residues will participate in the position-
ing of the dihydronicotinamide ring of NADH and the nico-
tinamide ring of NADPþ for hydride transfer during forma-
tion of the occluded state, as described above. After closure of
the site to expel water, they will also be responsible for the
polarisation that is evidenced by the elevated equilibrium con-
stant for the redox reaction.
Strictly, a true hydride transfer mechanism (as distinct from
a sequential electron/proton/electron transfer) remains unpro-
ven for transhydrogenase although experiments with nucleo-
tide analogues appear to rule out the formation of ‘high-
energy intermediates’ (single-electron oxidation products of
dihydronicotinamide and single-electron reduction products
of nicotinamide) in the reaction in solution [32]. The energy
required simultaneously to generate NADPþc and NADHc by
a single-electron transfer would probably be prohibitive (see
[33]) and hydride transfer is therefore the likely mechanism.
The temperature dependences of the primary kinetic isotope
e¡ect for AcPdADþ reduction by NADP2H/NADP1H in
dI2dIII1 complexes indicate that there may be a contribution
to the reaction from quantum-mechanical tunnelling of the
hydride ion through the activation barrier [19]. Hydrogen
tunnelling has been studied in detail in some soluble enzymes.
One attractive view [34] is that thermal £uctuations of the
ground state of the enzyme^substrate complex decrease the
distance over which the hydrogen must tunnel and thus accel-
erate the rate of reaction (and see review [35]).
8. Force generation by proton translocation through dII, and
energy transmission to the hydride transfer site
The balance of evidence suggests that proton translocation
through dII leads to conformational changes that are trans-
mitted across dIII to the hydride transfer site at the interface
of the latter with dI. Transhydrogenation activity is partially
inhibited when the dII residues, LHis91, LAsn222, LAsp213 or
those in the sequence LCys260^LSer266, of the E. coli enzyme
are substituted by mutagenesis [36^40], and these residues
might therefore be involved either in the conduction of pro-
tons through dII or in the energy-transduction device itself.
Presumably the propagation of the all-important conforma-
tional change will involve relative motions of rigid elements of
dII ^ most probably the TM helices ^ but the nature of these
motions is not known and, for clues, a high-resolution struc-
ture of the intact enzyme is awaited.
The core of dIII is L-sheet and, as such, is likely to be a
rather in£exible structure unsuitable for transmitting long-dis-
tance conformational changes between dII and the hydride
transfer site. The feature most likely to serve in energy trans-
mission across dIII is helix D/loop D [7,11]. This emerges at
90‡ from the C-terminus of the L-sheet. It passes close to the
NADPþ pyrophosphate group and then runs through a series
of H-bonded turns before rejoining the next strand in the
sheet. Helix D/loop D contains a large number of invariant
amino acid residues and, crucially, interacts with both the loop
E ‘lid’ of dIII and the RQD loop of dI (see above). It is
proposed that conformational changes in helix D/loop D,
driven by the events in dII that are associated with proton
translocation, regulate the opening of loop E (and thus the
exchange of NADP(H) with the solvent) and the width of the
dI cleft (and hence the movement of the NADH nicotinamide
ring that is required for hydride transfer). The invariant
Asp132 in helix D/loop D is located under the loop E lid.
Mutagenesis studies (in E. coli transhydrogenase) indicate
the importance of this residue and, though it was proposed
to be involved in the proton translocation pathway [40,41], we
can ¢nd no evidence of this from the X-ray structure. Rather,
we suggest that Asp132, which calculation indicates has a
substantially elevated pKa in isolated (occluded) dIII [3], is
involved in stabilising the structure of the lid in its closed
and retracted conformations [42].
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9. Signalling to the proton translocation gate
Since coupling is indirect, the proton translocation device
must be synchronised with the progress of the hydride transfer
reaction: access of the device to protons from one side of the
membrane or the other must be switched by the redox state of
the nucleotides ^ most probably of NADP(H). It is not clear
how this is achieved but an NMR experiment with isolated
dIII proteins reveals a highly localised region of magnetisation
change in the nicotinamide-binding pocket, in helix D/loop D
and in loop E, when NADPþ is replaced with NADPH. The
(heteronuclear single-quantum coherence) experiment, in
which the 1H and 15N spins of the amide groups in the protein
are correlated, has been performed with both R. rubrum [43]
and E. coli dIII [44]. It is not yet clear to what extent the
observed chemical shift changes represent atomic displace-
ments or electric polarisations in the protein but the localised
nature of the response in these important secondary structures
suggested to us that it might correspond to the signal trans-
mitted from the nucleotide-binding site to the membrane-
spanning dII to inform on the progress of the redox reaction
[12].
10. The alternation of sites in transhydrogenase
Intact transhydrogenase is essentially a dimer of two dI+-
dII+dIII ‘monomers’ (reviewed in [45]). However, in solution
[13] and in the crystalline state [7], only one isolated dIII
stably associates with the isolated dI dimer ^ but, nevertheless,
the single catalytic site between the single dI/dIII interface is
fully active. The symmetry of the dI2dIII1 complex clearly
reveals the position at which a second dIII can bind ^ into
the side of the cleft of the ‘vacant’ dI (see Fig. 1) ^ but
inserting a modelled copy of the ¢rst dIII into this site leads
to severe side-chain clashing between the two dIII polypep-
tides [7]. NMR experiments show that a second dIII can in-
teract with the dI2dIII1 ‘heterotrimer’ though with very low
a⁄nity [43]. These observations suggest that, in the intact
enzyme, the two dI/dIII sites must be alternately brought
together to allow hydride transfer. It was proposed that the
conformational changes responsible for coupling transhydro-
genation to proton translocation relate to the site alternation
[7]. Thus, as dI(A)/dIII(A) enters the open state to permit
product release and substrate binding, dI(B)/dIII(B) enters
the occluded state to permit hydride transfer (Fig. 2). The
conclusions from the structural work are strongly supported
by earlier covalent-modi¢cation and nucleotide-binding ex-
periments which revealed half-of-the-sites reactivity in intact
mitochondrial transhydrogenase [5].
The alternating-site mechanism might enable transhydroge-
nase better to balance its internal equilibria (compare the
principle enunciated for enzyme catalysis [46]). Invariant ami-
no acid residues and mutations that disrupt transhydrogenase
function (reviewed in [4]) are located mainly on the cytosolic
side of dII (in bacteria). This suggests that the transduction
device lies close to the dIII/dII interface, and therefore that
the dielectric drop for proton binding from the periplasm will
be larger than that for proton release to the cytoplasm. By
coupling together the A and the B sides of the protein dimer,
the energies available to drive the openHoccluded conforma-
tional changes would be equalised, promoting catalytic e⁄-
ciency. To achieve this, the two dII components would oper-
ate as a single integrated device in proton translocation ^
reciprocating motions between symmetry-related TM helices
in the two dII monomers would simultaneously drive dI(A)/
dIII(A) into the open state and dI(B)/dIII(B) into the oc-
cluded state (a ‘push-pull’ e¡ect). It is even conceivable that,
as in the F1FO-ATP synthase, there is just a single proton
channel with structural contributions from both dII(A) and
dII(B).
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